Shannon K Oda is a prominent inventor based in Lake Forest Park, WA (US). She has made significant contributions to the field of immunology, particularly through her innovative work on immunomodulatory fusion proteins. With a total of 3 patents, her research focuses on developing novel therapeutic approaches to combat diseases such as cancer and infectious diseases.

Latest Patents

Shannon K Oda's latest patents include groundbreaking work on immunomodulatory fusion proteins. These proteins contain an extracellular binding domain and an intracellular signaling domain, which can generate a modulatory signal in host cells, such as T cells. The first patent describes the use of immune cells expressing these fusion proteins to treat various diseases, including cancer and infectious diseases. The second patent elaborates on the design of these proteins, which may include a SIRPα extracellular component and components from CD28, capable of delivering a positive or costimulatory signal in response to a binding event that would typically result in an inhibitory signal.

Career Highlights

Shannon K Oda is affiliated with the Fred Hutchinson Cancer Center, where she continues her research and development of innovative therapies. Her work has garnered attention for its potential to revolutionize treatment options for patients suffering from serious health conditions.

Collaborations

Shannon has collaborated with notable colleagues in her field, including Philip D Greenberg and Thomas M Schmitt. These partnerships have further enhanced her research and contributed to the advancement of immunological therapies.

Conclusion

Shannon K Oda's contributions to the field of immunology through her patents and research at the Fred Hutchinson Cancer Center highlight her role as an influential inventor. Her work on immunomodulatory fusion proteins represents a significant step forward in the development of innovative treatments for critical diseases.

This text is generated by artificial intelligence and may not be accurate.